Respirology
Differentiating Causes of Dyspnea and Cough – Could your Patient have Interstitial Lung Disease?
Interstitial lung disease (ILD) is a group of pulmonary conditions that are characterized by diffuse parenchymal lung infiltration. This is caused by lung inflammation and/or lung fibrosis. Although less common than other respiratory conditions, ILD can be associated with significant mortality risk, higher than many different types of cancer. There is also a lack of public awareness of this condition. With treatments available to reduce ILD progression and mortality risk, time lost before diagnosis translates to lung lost. This program is designed to help provide the primary care clinician with guidance regarding when to suspect ILD and their role in the assessment and referral of these patients.
DURATION
1 hr
PROFESSION
Physician
# OF CREDITS
1.0
ACCREDITATION
Mainpro+
EXPIRY DATE
2025-04-23
Interstitial lung disease (ILD) is a large group of lung diseases affecting the tissue and space around the alveoli of the lungs, which cause progressive scarring of lung tissue through inflammation and/or fibrosis. This diminishes the lung’s capacity for alveolar gas diffusion. ILD is associated with significant morbidity and mortality. Although timely diagnosis is important to delay disease progression and prolong survival, there is commonly a delay of 7 months to more than 5 years from the onset of symptoms prior to diagnosis. Primary care clinicians play a crucial role in the initial assessment and referral of patients with suspected ILD. This program will provide the clinician with a quick review of when to suspect ILD, the initial testing and how to optimize referral to Respirology for a timely diagnosis.
This program has received financial support from Boehringer Ingelheim in the form of an unrestricted educational grant.
Faculty
Nooreen Mann, MD, FRCPC
Jessica Chan, MD, CCFP
Jeffrey Habert, MD, CCFP, FCFP
Bruno Bernucci, MD, CCFP
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- Explain the prevalence and impact of interstitial lung disease (ILD)
- Describe the barriers to identifying patients with ILD
- Determine the initial assessment of a patient with suspected ILD, including patient history, examination, and diagnostic tests
- Differentiate between ILD and other common conditions with similar clinical presentations
- Determine the role of primary care physicians in patients with IPF prescribed antifibrotic therapy
Accreditation
This self-learning program has been certified by the College of Family Physicians of Canada for up to 1.0 Mainpro+ credits.
Cert+ Program ID#: 202316.
#
of credits: 1.0
Duration: 1 hr
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
1 hr
Duration
Physician
Profession
1.0
# of credits
Learning Objectives
Upon completion of this continuing education program, participants will be better able to:
- Explain the prevalence and impact of interstitial lung disease (ILD)
- Describe the barriers to identifying patients with ILD
- Determine the initial assessment of a patient with suspected ILD, including patient history, examination, and diagnostic tests
- Differentiate between ILD and other common conditions with similar clinical presentations
- Determine the role of primary care physicians in patients with IPF prescribed antifibrotic therapy
Mainpro+
ACCREDITATION
Respirology
Learning Category
Lung Disease
Topic
0
Price
2025-04-23
Expiry Date
CAN-eng
Region/Language
Course Description
Interstitial lung disease (ILD) is a large group of lung diseases affecting the tissue and space around the alveoli of the lungs, which cause progressive scarring of lung tissue through inflammation and/or fibrosis. This diminishes the lung’s capacity for alveolar gas diffusion. ILD is associated with significant morbidity and mortality. Although timely diagnosis is important to delay disease progression and prolong survival, there is commonly a delay of 7 months to more than 5 years from the onset of symptoms prior to diagnosis. Primary care clinicians play a crucial role in the initial assessment and referral of patients with suspected ILD. This program will provide the clinician with a quick review of when to suspect ILD, the initial testing and how to optimize referral to Respirology for a timely diagnosis.
This program has received financial support from Boehringer Ingelheim in the form of an unrestricted educational grant.
Faculty
Nooreen Mann, MD, FRCPC
Jessica Chan, MD, CCFP
Jeffrey Habert, MD, CCFP, FCFP
Bruno Bernucci, MD, CCFP
Accreditation
This self-learning program has been certified by the College of Family Physicians of Canada for up to 1.0 Mainpro+ credits.
Cert+ Program ID#: 202316.
1 hr
Duration
0
Price
1.0
# of credits
